UCLA Psychiatry and Psychology CME Program - November 5, 2020 - May 2021
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
UCLA Psychiatry November 5, 2020 —
May 2021
Enroll and learn more at
www.psychiatrycme.ucla.edu
and Psychology A Virtual Program Walter Dunn MD, PhD
CME Program
Course Director
UCLA Psychiatry November 5, 2020 —
May 2021
Enroll and learn more at
www.psychiatrycme.ucla.edu
and Psychology
CME Program
Course Description
The UCLA Psychiatry and Psychology CME Program is designed to provide a practical review of evidenced-based
best practices in the diagnosis and treatment of psychiatric disorders for the mental health clinician. Psychiatrists,
psychologists, and therapists alike will benefit from the knowledge and expertise of our faculty from the UCLA Semel
Institute for Neuroscience and Human Behavior. Speakers will also highlight the latest in research findings providing
a perspective on the current and future state of the field.
This course will be divided into three blocks of presentations from Nov 2020 to May 2021. Participants will be able
to register and pay for each block separately. Updated presentation schedules and registration information will
be available at www.psychiatrycme.ucla.edu
Course Details Course Learning Objectives
The talks take place as live-streamed lectures. Presenta- At the conclusion of the course, participants should be able to:
tions will be pre-recorded and digitally edited to enhance
the learning experience for the viewer. A 15-20 minute live 1. Describe current evidence-based 5. Discuss what non-pharmacologic
question and answer session will follow each presentation practices with greater confidence to diag- treatment options are available for com-
with the presenter taking questions from viewers. nose and manage psychiatric conditions mon psychiatric disorders and for which
including, depression, schizophrenia, target symptoms they are most effective.
This longitudinal series will be comprised of 25 weekly bipolar disorder, substance use disorders,
lectures presented over 3 blocks. Registration and participa- anxiety, ADHD, and borderline personality 6. Explain how psychiatric medications
tion in all 25 presentations earns participants a maximum disorder. with abuse potential can be misused and
of 25 CME credits. appreciate how to minimize the potential
2. Discuss the prevalence of psychiatric for abuse.
Block 1 (Nov 2020 - Jan 2021) offers nine lectures conditions in specific age groups and how
Block 2 (Feb 2021 - Mar 2021) offers eight lectures management approaches can be tailored 7. Describe the scope of and treatments
Block 3 (Apr 2021 - May 2021) offers eight lectures taking into consideration patient age. for substance abuse disorders including
their prevalence in unique populations
Participants can also sign up for an individual block, and
3. Explain and appreciate cultural con- such as physicians.
earn a maximum number of CME credits equivalent to the
siderations when treating vulnerable
total lectures in that block.
populations such as LGBTQ individuals 8. Discuss patient attributes such as
or underrepresented minorities. gender, race, profession, and age and
Target Audience their role in increasing risk and associa-
This course will be targeted to clinicians of all levels who 4. Apply standard treatments for common tion with increased prevalence for certain
provide mental health treatment. Lectures will review psychiatric disorders and have a better psychiatric disorders and how treatment
information and skills useful for providers in the primary understanding of specialized and emerging approaches should consider these factors.
care setting, outpatient psychiatric practice, and tertiary therapeutic options for treatment-resistant
level specialty care. conditions.
Schedule November 5, 2020 —
May 2021
Enroll and learn more at
www.psychiatrycme.ucla.edu
Block 1 – November 2020 through January 2021
title speaker date
Update on Depression Michael Gitlin, MD Thurs 11/05/20 | 12-1PM PST
Update on Adult ADHD James McGough, MD Thurs 11/12/20 | 12-1PM PST
Family Focused Intervention
for Pediatric Anxiety and OCD Tara Peris, PhD Thurs 11/19/20 | 12-1PM PST
Psychiatric Effects of Cannabis Use Timothy Fong, MD Thurs 12/3/20 | 12-1PM PST
The Alphabet Soup
of Neuromodulation Treatments Andrew Leuchter, MD Thurs 12/10/20 | 12-1PM PST
Detection and Prevention of
Age-Associated Cognitive Decline Gary Small, MD Thurs 12/17/20 | 12-1PM PST
Update on Schizophrenia Stephen Marder, MD Thurs 01/07/20 | 12-1PM PST
Bipolar Disorder: New Data
and Current Controversies Michael Gitlin, MD Thurs 01/14/20 | 12-1PM PST
Cannabis Use Disorder:
Clinical Issues and Treatment Larissa Mooney, MD Thurs 01/21/20 | 12-1PM PST
Schedule November 5, 2020 —
May 2021
Enroll and learn more at
www.psychiatrycme.ucla.edu
Block 2 – February 2021 through March 2021
title speaker
Role of Ketamine in Managing Treatment-Resistant Depression Jennifer Kruse, MD
Non-Medication Alternatives for Treatment of ADHD in Children Sandra Loo, PhD
Innovation in Preventing Self-Harm in Youth Joan Asarnow, PhD
Update on Psychotherapies for Borderline Personality Disorder Robin Kissell, MD
The Genetic Basis of Psychiatric Disease Jonathan Flint, MD
Psychedelic-Assisted Psychotherapies Charles Grob, MD
Collaborative Behavioral Healthcare: What Do We Know? Jessica Jeffrey, MD, MBA, MPH
Mental Health Needs of LGBTQ Youth and Young Adults: Risk and Resiliency Brandon Ito, MD, MPH
Block 3 - April 2021 through May 2021
title speaker
Managing the Psychosis Prodrome Misty Richards, MD, MS
Memory and Cognitive Training in Older Adults Linda Ercoli, PhD
Substance Use in Medical Professionals Karen Miotto, MD
Treatment of Anxiety Disorders and Co-Occurring Substance Use Disorders Kate Taylor, PhD
Alcohol Use Disorder Clinical Effects and Pharmacotherapy Larissa Mooney, MD
Repetitive Transcranial Magnetic Stimulation (rTMS) for Major
Depressive Disorder through the Lifespan Jonathan Lee, MD, MSc
14 Ways to Lose Your License: Substance Use and Recovery in Physicians Karen Miotto, MD
Unraveling the Estrogen-Depression-Connection Across the Lifespan Karen Miller, PhD
Speakers November 5, 2020 —
May 2021
Enroll and learn more at
www.psychiatrycme.ucla.edu
cme course chair
Walter Dunn, MD, PhD Andrew Leuchter, MD Gary Small, MD
UCLA Assistant Professor of Clinical Psychiatry UCLA Professor of Psychiatry UCLA Professor of Psychiatry
Director of the Interventional Psychiatry Service, Director of the Neuromodulation Division Director of the UCLA Center on Aging
GLA-VA
James McGough, MD Larissa Mooney, MD Michael Gitlin, MD
UCLA Professor of Clinical Psychiatry UCLA Associate Professor of Clinical Psychiatry UCLA Professor of Clinical Psychiatry
Director of Clinical Programs in ADHD Director of UCLA Addiction Clinic Director of Mood Disorders Clinic
Stephen Marder, MD Tara Peris, PhD Timothy Fong, MD
UCLA Professor of Psychiatry UCLA Associate Professor of Psychiatry UCLA Associate Professor of Clinical
Director of Psychosis Clinic Director of ABC Children’s Partial Psychiatry, Director of UCLA Addiction
Hospitalization Program Psychiatry Fellowship
General November 5, 2020 —
May 2021
Enroll and learn more at
www.psychiatrycme.ucla.edu
Information
Refund Additional Information
Cancellations must be received in writing and will be subject to a $50 If you have any questions, please contact the UCLA Office of Continuing
processing fee. No refunds will be granted after the cancellation date. Medical Education at (310) 794-2620 or visit our CME website.
If, for any reason, the course must be cancelled, discontinued, or resched- Website: www.cme.ucla.edu
uled by the Office of Continuing Medical Education, a full refund will be Email: uclacme@mednet.ucla.edu
provided.
For Participants Registering for the Entire 3 Block Series:
Cancellation Deadline: Nov 11, 2020
For Participants Registering by Individual Blocks:
Block 1 Cancellation Deadline: Nov 11, 2020
Block 2 Cancellation Deadline: 7 days prior to first presentation of
Block 2 (TBD) (e.g. 1st lecture date Feb 11, 2021, last day to cancel: Feb 4, 2021)
Block 3 Cancellation Deadline: 7 days prior to first presentation of Block 3 (TBD)
Accreditation Disclosure Statement
The Office of Continuing Medical Education, David Geffen School of The FDA has issued a concept paper that classifies commercial support
Medicine at UCLA is accredited by the Accreditation Council for Continuing of scientific and educational programs as promotional unless it can be
Medical Education to provide continuing medical education for physicians. affirmed that the program is “truly independent” and free of commercial
The Office of Continuing Medical Education, David Geffen School of Med- influence. In addition to independence, the FDA requires that non-pro-
icine at UCLA, designates this live activity for a maximum of 25 AMA PRA motional, commercially supported education be objective, balanced and
Category 1 CreditsTM. Physicians should claim only the credit commensurate scientifically rigorous. The policy further states that all potential conflicts
with the extent of their participation in the activity. of interest of the CME staff and faculty be fully disclosed to the program’s
participants. In addition, Accreditation Council for Continuing Medical
Education policy mandates that the provider adequately manage all identi-
fied potential conflicts of interest prior to the program. UCLA fully endorses
the letter and spirit of these concepts.
You can also read
